NHS England to restructure senior management teams

NHS England has announced a restructure of its national senior management teams to enable it to deliver the Five Year Forward View (FYFV). This restructure marks a move away from its focus on planning and strategy.

The Commissioning Strategy directorate will be renamed as Strategy and Innovation and specialised commissioning is set to transfer to an expanded group under Paul Baumann, NHS England's Chief Financial Officer.

Matthew Swindells’ directorate, Operations and Information, is to be expanded giving it the largest brief with overall responsibility for the delivery of the FYFV. Mr Swindells’ remit will include primary care, and most of the FYFV improvement programmes including cancer and mental health. Former Director of Strategy, Michael Macdonnell has moved to a new role as Director of System Transformation where his work will be focused on the development of integrated health systems and incorporating work on new care models.

Recruitment for a new Medical Director and National Director for Transformation and Operations is expected to begin soon, following the departures of Sir Bruce Keogh and Karen Wheeler.

The Health Service Journal (HSJ) article on the restructure can be read here.

Page published: Mon 26 June 2017

It is supported by 9 companies:

  • Amgen
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Lilly
  • Novartis
  • Pfizer
  • Roche
  • Shire